2018 AANS Annual Scientific Meeting-Medulloblastomas in the Era of Molecular Biology: A Challenge for Developing Countries

Medulloblastomas in the Era of Molecular Biology: A Challenge for Developing Countries

Video Transcription

Video Summary

In this video, Dr. Ibaki from Algeria discusses the challenges faced by developing countries in the field of pediatric neurosurgery, specifically focusing on medulloblastomas. He talks about the heterogeneity of response to treatment and the need for better risk stratification based on molecular biology. He highlights the importance of advances in molecular biology in understanding the different subgroups of medulloblastomas and their implications for prognosis and treatment. Dr. Ibaki also discusses the limitations in access to advanced technologies, such as immunohistochemistry and fish analysis, in developing countries. He emphasizes the need for support from developed countries and investment in molecular biology to improve outcomes for patients in developing countries.

Asset Caption

Souad Bakhti, MD (Algeria)

Keywords

pediatric neurosurgery

medulloblastomas

molecular biology

developing countries

outcomes